US Stock MarketDetailed Quotes
BCTX BriaCell Therapeutics
- 0.982
- +0.140+16.63%
Close Nov 29 13:00 ET
- 0.960
- -0.022-2.28%
Post 16:05 ET
35.55MMarket Cap-3387P/E (TTM)
1.010High0.850Low1.52MVolume0.850Open0.842Pre Close1.42MTurnover4.79%Turnover RatioLossP/E (Static)36.18MShares5.97052wk High-14.88P/B31.10MFloat Cap0.46452wk Low--Dividend TTM31.65MShs Float12.470Historical High--Div YieldTTM19.00%Amplitude0.464Historical Low0.939Avg Price1Lot Size
BriaCell Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | (Q1)Oct 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 43.22%33.33M | -25.15%5.77M | 62.58%9.23M | 119.10%9.83M | 57.37%8.5M | 52.25%23.27M | 47.22%7.71M | 37.68%5.68M | 23.13%4.49M | 136.48%5.4M |
| Selling and administrative expenses | -22.47%6.15M | -46.32%1.36M | -13.46%1.57M | 9.70%1.57M | -23.38%1.65M | 9.19%7.94M | 22.91%2.54M | -2.05%1.82M | -26.08%1.43M | 52.43%2.15M |
| -General and administrative expense | -22.47%6.15M | -46.32%1.36M | -13.46%1.57M | 9.70%1.57M | -23.38%1.65M | 9.19%7.94M | 22.91%2.54M | -2.05%1.82M | -26.08%1.43M | 52.43%2.15M |
| Research and development costs | 77.21%27.18M | -14.75%4.41M | 98.36%7.66M | 170.44%8.26M | 110.65%6.86M | 91.19%15.34M | 63.07%5.17M | 70.16%3.86M | 78.75%3.05M | 271.75%3.26M |
| Operating profit | -43.22%-33.33M | 25.15%-5.77M | -62.58%-9.23M | -119.10%-9.83M | -57.37%-8.5M | -52.25%-23.27M | -47.22%-7.71M | -37.68%-5.68M | -23.13%-4.49M | -136.48%-5.4M |
| Net non-operating interest income expense | -67.68%288.02K | -100.00%2 | -93.84%15.61K | -66.09%81.6K | 1.31%190.82K | 556.50%891.21K | 153.50%208.78K | 604.39%253.49K | 1,891.52%240.6K | 3,436.48%188.35K |
| Non-operating interest income | -67.68%288.02K | -100.00%2 | -93.84%15.61K | -66.09%81.6K | 1.31%190.82K | 551.80%891.21K | 153.50%208.78K | 604.39%253.49K | 1,891.52%240.6K | 2,887.36%188.35K |
| Other net income (expense) | 1,252.34%28.11M | -11.01%4.52M | 1,965.18%10.91M | 79.23%-1.59M | 247.38%14.27M | 117.78%2.08M | 8.02%5.08M | 108.91%528.1K | -151.62%-7.64M | 116.27%4.11M |
| Gain on sale of security | 1,257.46%28.22M | -10.00%4.57M | 1,972.18%10.94M | 79.47%-1.57M | 247.38%14.27M | 117.78%2.08M | 8.02%5.08M | 108.91%528.1K | -151.62%-7.64M | 116.27%4.11M |
| Earnings from equity interest | ---106.51K | ---51.17K | ---37K | ---18.35K | ---- | --0 | --0 | --0 | --0 | ---- |
| Income before tax | 75.71%-4.93M | 48.37%-1.25M | 134.57%1.69M | 4.61%-11.33M | 638.51%5.96M | 24.35%-20.3M | -437.06%-2.42M | 51.12%-4.9M | -206.46%-11.88M | 95.98%-1.11M |
| Income tax | ||||||||||
| Net income | 75.71%-4.93M | 48.37%-1.25M | 134.57%1.69M | 4.61%-11.33M | 638.51%5.96M | 24.35%-20.3M | -437.06%-2.42M | 51.12%-4.9M | -206.46%-11.88M | 95.98%-1.11M |
| Net income continuous Operations | 75.71%-4.93M | 48.37%-1.25M | 134.57%1.69M | 4.61%-11.33M | 638.51%5.96M | 24.35%-20.3M | -437.06%-2.42M | 51.12%-4.9M | -206.46%-11.88M | 95.98%-1.11M |
| Minority interest income | -140.08K | -34.59K | -23.52K | -39.31K | -42.67K | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to the parent company | 76.40%-4.79M | 49.80%-1.21M | 135.05%1.72M | 4.94%-11.29M | 642.37%6M | 24.35%-20.3M | -437.06%-2.42M | 51.12%-4.9M | -206.46%-11.88M | 95.98%-1.11M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 76.40%-4.79M | 49.80%-1.21M | 135.05%1.72M | 4.94%-11.29M | 642.37%6M | 24.35%-20.3M | -437.06%-2.42M | 51.12%-4.9M | -206.46%-11.88M | 95.98%-1.11M |
| Basic earnings per share | 77.69%-0.29 | 53.33%-0.07 | 134.38%0.11 | 7.79%-0.71 | 642.86%0.38 | 24.86%-1.3 | -400.00%-0.15 | 50.77%-0.32 | -208.45%-0.77 | 96.13%-0.07 |
| Diluted earnings per share | 77.69%-0.29 | 53.33%-0.07 | 134.38%0.11 | 7.79%-0.71 | -614.29%-0.5 | 24.86%-1.3 | -400.00%-0.15 | 50.77%-0.32 | -208.45%-0.77 | 96.13%-0.07 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
